Oncotarget

Vol 9, No 97

December 11, 2018

View Archive »

Order a Reprint

About The Cover

The cover for issue 97 of Oncotarget features Figure 4, "Representative examples of FR expression detected on canine kidney," by Szigetvari, et al.

Table of Contents

Editorial

Premetastatic niche and tumor-related leukocytosis: a close relationship that cannot be ignored in uterine cancer patients

Premetastatic niche and tumor-related leukocytosis: a close relationship that cannot be ignored in uterine cancer patients

https://doi.org/10.18632/oncotarget.26425

Seiji Mabuchi, Tomoyuki Sasano,  and Naoko Komura
36889-36890
PDF  |  Order a Reprint

Research Perspectives

Modification of gastric cancer risk associated with proton pump inhibitors by aspirin after Helicobacter pylori eradication

Modification of gastric cancer risk associated with proton pump inhibitors by aspirin after Helicobacter pylori eradication

https://doi.org/10.18632/oncotarget.26382

Ka Shing Cheung,  and Wai K. Leung
36891-36893
Abstract  |  PDF  |  HTML  |  Order a Reprint

Research Papers

Biomarkers and polymorphisms in pancreatic neuroendocrine tumors treated with sunitinib

Biomarkers and polymorphisms in pancreatic neuroendocrine tumors treated with sunitinib

https://doi.org/10.18632/oncotarget.26380

Paula Jiménez-Fonseca, Miguel Navarro Martín, Alberto Carmona-Bayonas, Alfonso Calvo, Javier Fernández-Mateos, Miriam Redrado, Jaume Capdevila, Nieves Martínez Lago, Adelaida Lacasta, Javier Muñarriz, Ángel Segura, Josep Fuster, Francisco Barón, Marta Llanos, Raquel Serrano, Alfredo Castillo, Juan Jesús Cruz Hernández,  and Enrique Grande
36894-36905
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Evaluation of pre-mir-34a rs72631823 single nucleotide polymorphism in triple negative breast cancer: A case-control study

Evaluation of pre-mir-34a rs72631823 single nucleotide polymorphism in triple negative breast cancer: A case-control study

https://doi.org/10.18632/oncotarget.26385

Despoina Kalapanida, Flora Zagouri, Maria Gazouli, Eleni Zografos, Constantine Dimitrakakis, Spyridon Marinopoulos, Aris Giannos, Theodoros N. Sergentanis, Efstathios Kastritis, Evangelos Terpos,  and Meletios-Athanasios Dimopoulos
36906-36913
Abstract  |  PDF  |  HTML  |  Order a Reprint

TRAIL stabilization and cancer cell sensitization to its pro-apoptotic activity achieved through genetic fusion with arginine deiminase

TRAIL stabilization and cancer cell sensitization to its pro-apoptotic activity achieved through genetic fusion with arginine deiminase

https://doi.org/10.18632/oncotarget.26398

Elena Brin, Katherine Wu, Eleanor Dagostino, Mario Meng-Chiang Kuo, Yudou He, Wei-Jong Shia, Li-Chang Chen, Mariusz Stempniak, Richard Hickey, Robert Almassy, Richard Showalter,  and James Thomson
36914-36928
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Genomic loss of HLA alleles may affect the clinical outcome in low-risk myelodysplastic syndrome patients

Genomic loss of HLA alleles may affect the clinical outcome in low-risk myelodysplastic syndrome patients

https://doi.org/10.18632/oncotarget.26405

Paola Montes, Martin Kerick, Mónica Bernal, Francisca Hernández, Pilar Jiménez, Pilar Garrido, Ana Márquez, Manuel Jurado, Javier Martin, Federico Garrido,  and Francisco Ruiz-Cabello
36929-36944
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Bioenergetic modulation with the mitochondria uncouplers SR4 and niclosamide prevents proliferation and growth of treatment-naïve and vemurafenib-resistant melanomas

Bioenergetic modulation with the mitochondria uncouplers SR4 and niclosamide prevents proliferation and growth of treatment-naïve and vemurafenib-resistant melanomas

https://doi.org/10.18632/oncotarget.26421

James L. Figarola, Jyotsana Singhal, Sharad Singhal, Jyotirmoy Kusari,  and Arthur Riggs
36945-36965
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Time to progression to castration-resistant prostate cancer after commencing combined androgen blockade for advanced hormone-sensitive prostate cancer

Time to progression to castration-resistant prostate cancer after commencing combined androgen blockade for advanced hormone-sensitive prostate cancer

https://doi.org/10.18632/oncotarget.26426

Satoshi Tamada, Taro Iguchi, Minoru Kato, Jumpei Asakawa, Kazuaki Kita, Sayaka Yasuda, Takeshi Yamasaki, Yudai Matsuoka, Kazuyuki Yamaguchi, Kentaro Matsumura, Ishun Go, Tetsuji Ohmachi,  and Tatsuya Nakatani
36966-36974
Abstract  |  PDF  |  HTML  |  Order a Reprint

Insight into the PTEN – p85α interaction and lipid binding properties of the p85α BH domain

Insight into the PTEN – p85α interaction and lipid binding properties of the p85α BH domain

https://doi.org/10.18632/oncotarget.26432

Jeremy D.S. Marshall, Paul Mellor, Xuan Ruan, Dielle E. Whitecross, Stanley A. Moore,  and Deborah H. Anderson
36975-36992
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

CD39+ regulatory T cells accumulate in colon adenocarcinomas and display markers of increased suppressive function

CD39+ regulatory T cells accumulate in colon adenocarcinomas and display markers of increased suppressive function

https://doi.org/10.18632/oncotarget.26435

Filip Ahlmanner, Patrik Sundström, Paulina Akeus, Jenny Eklöf, Lars Börjesson, Bengt Gustavsson, Elinor Bexe Lindskog, Sukanya Raghavan,  and Marianne Quiding-Järbrink
36993-37007
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

The high-sensitivity modified Glasgow prognostic score is superior to the modified Glasgow prognostic score as a prognostic predictor for head and neck cancer

The high-sensitivity modified Glasgow prognostic score is superior to the modified Glasgow prognostic score as a prognostic predictor for head and neck cancer

https://doi.org/10.18632/oncotarget.26438

Nobuhiro Hanai, Michi Sawabe, Takahiro Kimura, Hidenori Suzuki, Taijiro Ozawa, Hitoshi Hirakawa, Yujiro Fukuda,  and Yasuhisa Hasegawa
37008-37016
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Second-line treatment after sunitinib therapy in patients with renal cell carcinoma: a comparison of axitinib and mammalian target of rapamycin inhibitors

Second-line treatment after sunitinib therapy in patients with renal cell carcinoma: a comparison of axitinib and mammalian target of rapamycin inhibitors

https://doi.org/10.18632/oncotarget.26439

Satoshi Tamada, Taro Iguchi, Minoru Kato, Sayaka Yasuda, Takeshi Yamasaki,  and Tatsuya Nakatani
37017-37025
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

NEO412: A temozolomide analog with transdermal activity in melanoma in vitro and in vivo

NEO412: A temozolomide analog with transdermal activity in melanoma in vitro and in vivo

https://doi.org/10.18632/oncotarget.26443

Steve Swenson, Catalina Silva-Hirschberg, Weijun Wang, Anupam Singh, Florence M. Hofman, Kristen L. Chen, Axel H. Schönthal,  and Thomas C. Chen
37026-37041
Abstract  |  PDF  |  HTML  |  Order a Reprint

Phase I/II clinical trial of the targeted chemotherapeutic drug, folate-tubulysin, in dogs with naturally-occurring invasive urothelial carcinoma

Phase I/II clinical trial of the targeted chemotherapeutic drug, folate-tubulysin, in dogs with naturally-occurring invasive urothelial carcinoma

https://doi.org/10.18632/oncotarget.26455

Nicholas M. Szigetvari, Deepika Dhawan, José A. Ramos-Vara, Christopher P. Leamon, Patrick J. Klein, A. Audrey Ruple, Hock Gan Heng, Michael R. Pugh, Satish Rao, Iontcho R. Vlahov, Pierre L. Deshuillers, Philip S. Low, Lindsey M. Fourez, Ashleigh M. Cournoyer,  and Deborah W. Knapp
37042-37053
Abstract  |  PDF  |  HTML  |  Order a Reprint

Metformin alters H2A.Z dynamics and regulates androgen dependent prostate cancer progression

Metformin alters H2A.Z dynamics and regulates androgen dependent prostate cancer progression

https://doi.org/10.18632/oncotarget.26457

Monica Tyagi, Manjinder S. Cheema, Deanna Dryhurst, Christopher H. Eskiw,  and Juan Ausió
37054-37068
Abstract  |  PDF  |  HTML  |  Order a Reprint

Reviews

Radioresistance of cancer cells, integrin αvβ3 and thyroid hormone

Radioresistance of cancer cells, integrin αvβ3 and thyroid hormone

https://doi.org/10.18632/oncotarget.26434

John T. Leith, Shaker A. Mousa, Aleck Hercbergs, Hung-Yun Lin,  and Paul J. Davis
37069-37075
Abstract  |  PDF  |  HTML  |  Order a Reprint

Corrections

Correction: BNIP3 modulates the interface between B16-F10 melanoma cells and immune cells

Correction: BNIP3 modulates the interface between B16-F10 melanoma cells and immune cells

https://doi.org/10.18632/oncotarget.26474

Erminia Romano, Nicole Rufo, Hannelie Korf, Chantal Mathieu, Abhishek D. Garg,  and Patrizia Agostinis
37076-37076
Correction  |  PDF

Correction: PD-L1 expression heterogeneity in non-small cell lung cancer: evaluation of small biopsies reliability

Correction: PD-L1 expression heterogeneity in non-small cell lung cancer: evaluation of small biopsies reliability

https://doi.org/10.18632/oncotarget.26475

Enrico Munari, Giuseppe Zamboni, Marcella Marconi, Marco Sommaggio, Matteo Brunelli, Guido Martignoni, George J. Netto, Francesca Moretta, Maria Cristina Mingari, Matteo Salgarello, Alberto Terzi, Vincenzo Picece, Carlo Pomari, Gianluigi Lunardi, Alberto Cavazza, Giulio Rossi, Lorenzo Moretta,  and Giuseppe Bogina
37077-37077
Correction  |  PDF


Copyright © 2019 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC